3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) saw a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 6,115,388 shares, a growth of 135.0% from the June 15th total of 2,602,749 shares. Based on an average daily volume of 25 shares, the short-interest ratio is currently 244,615.5 days.
3SBio Stock Performance
OTCMKTS TRSBF opened at $2.15 on Wednesday. The firm has a 50-day simple moving average of $2.38 and a 200 day simple moving average of $2.76. 3SBio has a twelve month low of $2.00 and a twelve month high of $4.74.
3SBio Company Profile
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
Recommended Stories
- Five stocks we like better than 3SBio
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
